Literature DB >> 4029886

Transferrin metabolism in alcoholic liver disease.

B J Potter, R W Chapman, R M Nunes, D Sorrentino, S Sherlock.   

Abstract

The metabolism of transferrin was studied using purified 125I-labeled transferrin in 11 alcoholic patients; six with fatty liver and five with cirrhosis. Six healthy subjects whose alcohol intake was les than 40 gm daily were studied as a control group. There were no significant differences in the mean fractional catabolic rate and plasma volume in the alcoholic groups when compared with control subjects. A significantly decreased mean serum transferrin concentration was found in the alcoholic cirrhotic patients (1.8 +/- 0.3 gm per liter vs. 2.9 +/- 0.2; p less than 0.01), resulting from diminished total body synthesis (0.9 +/- 0.2 mg per kg per hr vs. 1.8 +/- 0.2; p less than 0.01). In contrast, in the patients with alcoholic fatty liver, the mean total body transferrin synthesis (2.4 +/- 0.3 mg per kg per hr) was significantly increased when compared with controls (p less than 0.05). For all the alcoholic patients, the serum transferrin correlated with transferrin synthesis (r = + 0.70; p less than 0.01) but the serum iron did not. These results suggest that, in alcoholic cirrhosis, transferrin synthesis is decreased, probably reflecting diminished synthetic capacity by the liver. In contrast, in patients with alcoholic fatty liver, transferrin turnover is accelerated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029886     DOI: 10.1002/hep.1840050503

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

Review 1.  The role of transferrin in the mechanism of cellular iron uptake.

Authors:  K Thorstensen; I Romslo
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

Review 2.  Iron and iron-related proteins in alcohol consumers: cellular and clinical aspects.

Authors:  Kevin Ferrao; Najma Ali; Kosha J Mehta
Journal:  J Mol Med (Berl)       Date:  2022-10-10       Impact factor: 5.606

3.  Differential patterns of liver proteins in experimental murine hepatosplenic schistosomiasis.

Authors:  B Manivannan; P Rawson; T W Jordan; W E Secor; A C La Flamme
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

Review 4.  Fetal alcohol syndrome: the vulnerability of the developing brain and possible mechanisms of damage.

Authors:  J R West; W J Chen; N J Pantazis
Journal:  Metab Brain Dis       Date:  1994-12       Impact factor: 3.584

Review 5.  Role of alcohol in the regulation of iron metabolism.

Authors:  Duygu Dee Harrison-Findik
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

6.  Increased serotransferrin and ceruloplasmin turnover in diet-controlled patients with type 2 diabetes.

Authors:  Makan Golizeh; Kwangwon Lee; Serguei Ilchenko; Abdullah Ösme; James Bena; Rovshan G Sadygov; Sangeeta R Kashyap; Takhar Kasumov
Journal:  Free Radic Biol Med       Date:  2017-10-25       Impact factor: 7.376

7.  Ethanol selectively impairs clathrin-mediated internalization in polarized hepatic cells.

Authors:  David J Fernandez; Benita L McVicker; Dean J Tuma; Pamela L Tuma
Journal:  Biochem Pharmacol       Date:  2009-05-20       Impact factor: 5.858

8.  Mechanisms of alcohol-induced endoplasmic reticulum stress and organ injuries.

Authors:  Cheng Ji
Journal:  Biochem Res Int       Date:  2011-10-26

9.  Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B.

Authors:  Hyo Jung Cho; Soon Sun Kim; Seun Joo Ahn; Joo Han Park; Dong Joon Kim; Young Bae Kim; Sung Won Cho; Jae Youn Cheong
Journal:  Clin Mol Hepatol       Date:  2014-12-24

10.  Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkers.

Authors:  Kevin J Fagan; Katharine M Irvine; Brett C McWhinney; Linda M Fletcher; Leigh U Horsfall; Lambro Johnson; Peter O'Rourke; Jennifer Martin; Ian Scott; Carel J Pretorius; Jacobus P J Ungerer; Elizabeth E Powell
Journal:  BMC Gastroenterol       Date:  2014-05-22       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.